Kim D. Blickenstaff - 11 Jun 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: Director
Issuer ticker: NUVB
Reported as of: 11 Jun 2024
Net transaction value: +$500,089
SEC form: 4
Accepted by SEC: 13 Jun 2024, 16:33:29 UTC
Prior SEC filing: 24 May 2024
Next SEC filing: 05 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Ron Metzger, Attorney-in-Fact

Key filing fact

Kim D. Blickenstaff filed Form 4 for Nuvation Bio Inc. (NUVB) on 13 Jun 2024.

Key facts

This page summarizes Kim D. Blickenstaff's Form 4 filing for Nuvation Bio Inc. (NUVB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Jun 2024, 16:33.

Change

Previous filing in this sequence was filed on 24 May 2024.
Current net transaction value: +$500,089.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Purchase

Transaction value: $500,089
Shares: +172,189
Change %
Price: $2.90
Shares after: 172,189
Date: 11 Jun 2024
Ownership: By Trust
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $2.835 to $2.96. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Shares are held directly by Kim D. Blickenstaff, Trustee of the Kim Blickenstaff Revocable Trust dated April 15, 2010.